Skip to content

JBIO JBIO Return on invested capital

Return on invested capital at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
26.8%+23.0pp
Climb Global Solutions, Inc. logo
Climb Global Solutions, Inc.CLMB
30.5%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-118%-48.4pp
Vera Therapeutics logo
Vera TherapeuticsVERA
-77.1%+219pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-255.3%-510pp
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-58%+22.6pp

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+316%
Enterprise value$1.27B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Calculated from JBIO’s reported figures.

Based on trailing twelve months.

The official record: JBIO’s 10-Q, filed May 13, 2024, on SEC EDGAR. View the filing →

Ask your AI about JBIO's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's return on invested capital?
JBIO (JBIO) reported return on invested capital of -104% in Q1 2024.
How has JBIO's return on invested capital changed year-over-year?
JBIO's return on invested capital decreased by 96.4% year-over-year, from -52.9% to -104%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.